The FTSE 100 index climbed 23.61 points, 0.3%, at 8,122.63. The FTSE 250 edged up 22.23 points, 0.1%, at 20,449.85, and the AIM All-Share was up 2.56 points, 0.4%, at 726.79.

(Alliance News) - Sage Group PLC on Wednesday announced a GBP400 million share buyback and said strong sales in its Cloud business had boosted annual revenue. The Newcastle-upon-Tyne, England-based ...

UBS raises AstraZeneca to 'neutral' (sell) - price target 11,300 pence ...

(Alliance News) - Russia's "irresponsible rhetoric" on nuclear weapons will not deter UK support for Ukraine, Prime Minister Keir Starmer has said.

According to the Office for National Statistics, the rate of annual consumer price inflation picked up to 2.3% in October, back above the Bank of England's target, from 1.7% in September. The latest ...

(Alliance News) - Stocks in London are set to open a touch higher on Wednesday, clawing back Tuesday's loss, with focus in the morning on a UK inflation reading. IG says futures indicate the FTSE 100 ...

The group also swung to a net surplus of GBP994,000 on the valuation of its investment properties, from a deficit of GBP2.2 million a year prior. This surplus offset an operating loss of GBP328,000 ...

Leeds had until September 27 to make an acquisition or be re-admitted to AIM as an investing company, in which case the firm would have needed to raise at least GBP6 million. Leeds failed to meet ...

Rockwood Strategic swung to a pretax return of GBP15.2 million from a loss of GBP3.0 million the year before, as it also swung to a net gain of GBP16.7 million on investments at fair value, from a ...

(Alliance News) - Fianna Fail would be open to negotiating with a number of centre ground parties post-election, Micheal Martin insisted as he pushed back on suggestions he was eyeing Labour as ...

(Alliance News) - Aquis Exchange PLC on Tuesday announced that Glenn Collinson has decided to step down as chair and director of Aquis with immediate effect for personal reasons. Aquis Exchange covers ...

Women with incurable breast cancer in England and Wales will not be offered a life-extending drug on the national health service after talks between the NHS spending watchdog and its manufacturer ...